BWI: Centaur Pharma, Makers of Sinarest Celebrate “Anticold Day” and “Common Cold Awareness Week” for the Second Year

Press release from Business Wire India
Source: Centaur Pharmaceuticals Private Limited
Wednesday, September 15, 2010 10:00 AM IST (04:30 AM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
Centaur Pharma, Makers of Sinarest Celebrate "Anticold Day" and "Common Cold Awareness Week" for the Second Year


Mumbai, Maharashtra, India, Wednesday, September 15, 2010 -- (Business Wire India) -- Common cold, although a self limiting disease, is responsible for more loss of work days and school days than any other disease. To increase awareness regarding prevention and spread of common cold, Centaur Pharma, makers of Sinarest, the No.1 Rx anticold, had commemorated "Anticold Day" and "Common Cold Awareness Week" programs for the first time in India in the year 2009.

This year once again Centaur Pharma celebrating Anticold Day on 15th Sept and Common Cold Awareness Week during 13th-18th Sept through various programs across India. As a part of the activities, information on do's and don'ts, myths and facts about the common cold will be disseminated through medical fraternity.

S.D. Sawant, CMD, Centaur Pharma, said, "Such acute conditions as common cold cause substantial productivity losses and missed school days because of high prevalence in related age groups. Common cold at times is indicative of underlying serious pathology and can sometimes lead to complications if unattended." Further he added that strong marketing team of over 1000 medical representatives of Centaur Pharma will facilitate this program with the help of doctors across the country.

About Centaur Pharmaceuticals Private Limited (www.centaurpharma.com)

Centaur was established in Mumbai, India, in 1978. Centaur ranks among India's Top 50 pharmaceutical players. In India, Centaur brands are leaders in 6 therapy segments, including the anticold segment, with Sinarest. Centaur is India's largest manufacturer and exporter of psychotropic API, with an USFDA approved facility. Centaur is strategically positioned in the contract manufacturing space with its UKMHRA and TGA, Australia, approved formulations facility in Pune. Centaur has built competencies in clinical research space with capabilities to conduct BA-BE studies and phase II/III/IV trials.

To view photographs kindly click on PIC1, PIC2
For picture(s)/data to illustrate this release click below:

http://www.BusinessWireIndia.com/attachments/PIC1(129).jpg
PIC1(129).jpg
http://www.BusinessWireIndia.com/attachments/PIC2(60).jpg
PIC2(60).jpg


CONTACT DETAILS
Prabhakar Bethi General Manager (Marketing), Centaur Pharmaceuticals Private Limited, +91 9320053718 +91 (22) 66499153, pbethi@centaurlab.com

KEYWORDS
CONSUMER, MARKETING, BUSINESS SERVICES, HEALTHCARE, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com